An infectious disease specialist shares his concerns that the risks of the monkeypox outbreak have been minimized, and that the response to date has been inadequate.
A specialist in tropical and infectious diseases describes the advance represented by Medicago s Covifenz vaccine and questions the World Health Organization s position on it.